Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | DHFR | P00374 | 1/20 | 0.38 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | AGXT | P21549 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7231237 | 1.00 | L3MBTL1 (0.42) | L3MBTL1TDP1ALDH1A1MEN1POLB | |
| SCHEMBL21388207 | 0.88 | L3MBTL1 (0.48) | L3MBTL1TDP1ALDH1A1MEN1POLB | |
| SCHEMBL7528742 | 0.84 | HTR1B (0.46) | L3MBTL1TDP1ALDH1A1MEN1POLB | |
| SCHEMBL10523172 | 0.83 | ALDH1A1 (0.43) | ALDH1A1MEN1POLBHPGDKMT2A | |
| SCHEMBL11669016 | 0.82 | S1PR4 (0.49) | L3MBTL1ALDH1A1MEN1POLBHPGD | |
| SCHEMBL878692 | 0.82 | FAAH (0.53) | L3MBTL1TDP1ALDH1A1MEN1POLB | |
| SCHEMBL3064992 | 0.82 | L3MBTL1 (0.41) | L3MBTL1TDP1ALDH1A1MEN1POLB | |
| SCHEMBL21601494 | 0.82 | KDM4E (0.54) | ALDH1A1MEN1POLBHPGDKMT2A | |
| SCHEMBL29546953 | 0.82 | KDM4E (0.54) | ALDH1A1MEN1POLBHPGDKMT2A | |
| SCHEMBL10458633 | 0.82 | HTR2A (0.50) | L3MBTL1TDP1ALDH1A1MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320214-A1 | ORGANIC COMPOUNDS | INTRA CELLULAR THERAPIES INC (US) | 2025-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250320214-A1 | ORGANIC COMPOUNDS | OPRD1, OPRK1, OPRM1 | L3MBTL1 3475/4885TDP1 3327/4885ALDH1A1 942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.